Giant pharmaceutical GSK announces positive data for Endometrial cancer drug Dostarlimab
GlaxoSmithKline (GSK) oncology subsidiary Tesaro has unveiled promising data from its Phase I/II Garnet study evaluating dostarli...Read More
Showing posts with label potential of dostarlimab in treating patients.. Show all posts
Showing posts with label potential of dostarlimab in treating patients.. Show all posts
Subscribe to:
Posts
(
Atom
)
